2020
DOI: 10.1021/jasms.9b00102
|View full text |Cite
|
Sign up to set email alerts
|

Simultaneous Analysis of Multiple Cancer Biomarkers Using MALDI-TOF Mass Spectrometry Based on a Parylene-Matrix Chip

Abstract: Recently, the parylene-matrix chip was developed for quantitative analysis of small molecules less than 1 kDa. In this study, MALDI-TOF MS based on the parylene-matrix chip was performed to clinically diagnose intrahepatic cholangiocarcinoma (IHCC) and colorectal cancer (CRC). The parylene-matrix chip was applied for the detection of small cancer biomarkers, including N-methyl-2-pyridone-5-carboxamide (2PY), glutamine, lysophosphatidylcholine (LPC) 16:0, and LPC 18:0. The feasibility of MALDI-TOF MS based on t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(16 citation statements)
references
References 36 publications
0
16
0
Order By: Relevance
“…Furthermore, a prospective metabolomics study discovered that higher levels of saturated LPC 18:0 reduced the risk of most common cancers [ 155 ], while higher levels of 8 different LPCs correlated with lower risk of advanced stage prostate cancer [ 156 ]. To enable high-throughput and quantitative analysis of LPCs as cancer biomarkers a novel parylene matrix biochip was recently developed and validated for clinical diagnosis [ 157 ].…”
Section: Future Directions Of Lpc As a Biomarkermentioning
confidence: 99%
“…Furthermore, a prospective metabolomics study discovered that higher levels of saturated LPC 18:0 reduced the risk of most common cancers [ 155 ], while higher levels of 8 different LPCs correlated with lower risk of advanced stage prostate cancer [ 156 ]. To enable high-throughput and quantitative analysis of LPCs as cancer biomarkers a novel parylene matrix biochip was recently developed and validated for clinical diagnosis [ 157 ].…”
Section: Future Directions Of Lpc As a Biomarkermentioning
confidence: 99%
“…Typically, matrices are known to be fragmented when they are exposed to laser radiation . When organic matrices such as CHCA were used as a sample for MALDI-ToF mass spectrometry (Case 2 in Figure b), there were unreproducible mass peaks at the low m / z ratio of less than 500, as in the previous works . Therefore, the mass peaks of amino acids in the molecular weight range 100–200 Da were difficult to isolate from the mass peaks of fragmented matrix molecules.…”
Section: Resultsmentioning
confidence: 86%
“…The relative standard deviation (RSD = m/σ × 100 in %) and the reproducibility (%) were calculated to be 100-RSD. 9 As shown in Figure 4a, the spot-to-spot reproducibility was estimated at five independent sample spots to be 61.5% for conventional MALDI-ToF mass spectrometry and 96.0% for LDI-ToF mass spectrometry. The mass spectrum for the reproducibility calculation is presented in Supporting Information (Figure S4a).…”
Section: ■ Results and Discussionmentioning
confidence: 98%
See 2 more Smart Citations